A randomized, single-blind, parallel-group clinical study to evaluate the effect of soluble b-1,3/1,6-glucan on experimental gingivitis in man
: Blackwell Synergy
Background: Gingivitis is an inflammatory disorder of the periodontium induced by
dental plaque bacteria. Soluble b-1,3/1,6-glucan (SBG) is known to enhance infection
defense by preventing excessive inflammatory responses caused by bacterial
Aim: The aim of the present study was to investigate the effect of SBG on
experimental gingivitis in man.
Material and Methods: Experimental gingivitis was induced over a period of 24 days
in 30 healthy volunteers who were simultaneously treated with SBG. Two groups
(n510/group) rinsed twice daily with an SBG mouthwash that was either swallowed
or expectorated. A third group (n510) received a water rinse as a control. Plaque
index (Pl.I), gingival index (GI), and amount of gingival crevicular fluid (GCF) were
assessed at baseline and at six times during the study.
Results: The results showed that in the SBG groups, GCF decreased significantly
during the study. The swallow group experienced a significant increase in GCF during
the first week. The control group followed the expected pattern of experimental
gingivitis, with a significant increase in the gingival fluid secretion during the test period.
There was a significant increase in GI and Pl.I during the study for all groups, with no
significant differences between them. No adverse effects of SBG were recorded.
Conclusions: In this 24-day experimental gingivitis study of subjects who used either
a SBG or a control mouthrinse: (1) all subjects had increased plaque and gingivitis, (2)
GCF increased in control-rinse subjects and GCF decreased in SBG-rinse subjects. The
only statistically significant difference between the SBG-rinse and control-rinse
subjects was an increase in GCF at day 7 for subjects who rinsed and swallowed SBG.
Daftar copy :
||Ruang Referensi - Perpustakaan FKIK
Diproses dalam : 0.2375168800354 detik